Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183032
Max Phase: Preclinical
Molecular Formula: C28H47N2O10P
Molecular Weight: 602.66
Associated Items:
ID: ALA5183032
Max Phase: Preclinical
Molecular Formula: C28H47N2O10P
Molecular Weight: 602.66
Associated Items:
Canonical SMILES: CCCCCCCCCCCOc1cccc(CCC(=O)NC[C@@H](O)COP(=O)(O)OC[C@@H](NC(C)=O)C(=O)O)c1
Standard InChI: InChI=1S/C28H47N2O10P/c1-3-4-5-6-7-8-9-10-11-17-38-25-14-12-13-23(18-25)15-16-27(33)29-19-24(32)20-39-41(36,37)40-21-26(28(34)35)30-22(2)31/h12-14,18,24,26,32H,3-11,15-17,19-21H2,1-2H3,(H,29,33)(H,30,31)(H,34,35)(H,36,37)/t24-,26-/m1/s1
Standard InChI Key: JKWADKHSHHOHDF-AOYPEHQESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 602.66 | Molecular Weight (Monoisotopic): 602.2968 | AlogP: 3.73 | #Rotatable Bonds: 24 |
Polar Surface Area: 180.72 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.89 | CX Basic pKa: | CX LogP: 3.40 | CX LogD: -2.32 |
Aromatic Rings: 1 | Heavy Atoms: 41 | QED Weighted: 0.09 | Np Likeness Score: 0.00 |
1. Sayama M, Uwamizu A, Ikubo M, Chen L, Yan G, Otani Y, Inoue A, Aoki J, Ohwada T.. (2021) Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine., 64 (14.0): [PMID:34233115] [10.1021/acs.jmedchem.1c00347] |
Source(1):